Delivery Order SPE2DB22D9239-SPE2DB25FDG01

Award Date 1/17/25
Potential Completion Date 2/10/25
Potential Value $48K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,520.80 contract is for the supply of Privigen 10% vial (400 mL) and has an ultimate completion date of October 21, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,092.96 contract is for the delivery of the pharmaceutical product Privigen 10% vial, 50ml. The contract has an ultimate completion date of January 27, 2023 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $32,004.00, is for the delivery of Privigen 10% vial, a 200 ml immunoglobulin product, with a completion date of June 13, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which runs through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Privigen 10% vial, 50 mL, a specialized pharmaceutical product, at a firm fixed price of $3,293.40. The contract has an ultimate completion date of January 10, 2025 and was awarded on December 18, 2024. DMS Pharmaceutical Group holds a significant single-award Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $35,492.40, is for the delivery of Privigen 10% vial 200ml, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,616.20, is for the delivery of Privigen 10% Vial 50ML, a pharmaceutical product, with a period of performance through March 10, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $16,002.00, is for the delivery of Privigen 10% vial in 100 mL quantities to support the medical supply needs of military health facilities. The contract has an ultimate completion date of July 2, 2024 and is a firm fixed-price delivery order. DMS Pharmaceutical Group holds a larger indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract, worth up to $32,004.00, is for the delivery of Privigen 10% vial (400 ml) with a completion date of April 4, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract, valued at up to $4,999,999 through 2025, which enables DLA to issue firm fixed-price orders for a wide...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $41,539.50, is for the delivery of Privigen 10% vial 200ml, a pharmaceutical product. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,934 contract is for the delivery of Privigen 10% vial, a 200 ml injectable immunoglobulin product, with a performance period ending on December 12, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB25FDG01
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $47,951.42, is for the delivery of Privigen 10% Vial 200mL, a specialized pharmaceutical product. The contract has an ultimate completion date of February 10, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. is the prime contractor and is responsible for providing the required pharmaceutical product to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items.

Generated 4/18/25, 2:18 PM